Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT2506 vs Simponi in Active Psoriatic Arthritis
NCT05046431Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- May 2021
- Primary completion
- Oct 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of BAT2506 in psoriatic arthritis (PsA), sponsored by Bio-Thera Solutions, Ltd.. Started May 2021; status: completed.
02
Drugs
BAT2506
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT05046431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05046431.